Search

everythinglearnresearchcommunity

for

Search:↓

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

A woman and her daughter had thallium poisoning from a herbal drink and rodenticide, causing hair loss and other symptoms.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

The lecture concluded that drugs for human enhancement are here to stay and called for their responsible development and fair access.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

Scientists created a 3D skin model to study a chronic skin disease and test treatments.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Hair loss treatment caused more hair loss in a man.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Researchers created a potential skin substitute using a biodegradable mat that supports skin cell growth and layer formation.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Severe hair loss links to metabolic issues in older men with psoriasis.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Entrepreneurial companies are key to advancing dermatology treatments and patient care.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

Newly divided skin cells quickly move to join skin structures due to tissue tension and specific signals.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.